Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyramidal Cells | 24 | 2024 | 151 | 5.730 |
Why?
|
| CA1 Region, Hippocampal | 10 | 2025 | 68 | 5.320 |
Why?
|
| Neuronal Plasticity | 18 | 2026 | 283 | 4.810 |
Why?
|
| Dendrites | 23 | 2022 | 180 | 4.140 |
Why?
|
| Synapses | 17 | 2026 | 425 | 3.520 |
Why?
|
| Hippocampus | 21 | 2026 | 794 | 3.420 |
Why?
|
| Memory | 8 | 2026 | 306 | 3.330 |
Why?
|
| Place Cells | 3 | 2025 | 18 | 2.230 |
Why?
|
| Entorhinal Cortex | 3 | 2024 | 28 | 2.050 |
Why?
|
| Learning | 4 | 2026 | 353 | 1.970 |
Why?
|
| Action Potentials | 15 | 2021 | 472 | 1.850 |
Why?
|
| Nerve Net | 6 | 2025 | 253 | 1.740 |
Why?
|
| CA3 Region, Hippocampal | 3 | 2024 | 17 | 1.710 |
Why?
|
| Neurons | 13 | 2024 | 1977 | 1.600 |
Why?
|
| Membrane Potentials | 7 | 2020 | 293 | 1.420 |
Why?
|
| Synaptic Transmission | 4 | 2020 | 299 | 1.250 |
Why?
|
| Spatial Navigation | 2 | 2020 | 21 | 1.080 |
Why?
|
| Behavior, Animal | 6 | 2018 | 475 | 1.060 |
Why?
|
| Neural Inhibition | 4 | 2017 | 107 | 1.010 |
Why?
|
| Interneurons | 4 | 2017 | 144 | 0.970 |
Why?
|
| Animals | 51 | 2026 | 33726 | 0.970 |
Why?
|
| Spatial Learning | 1 | 2025 | 15 | 0.890 |
Why?
|
| Rats | 24 | 2015 | 3374 | 0.840 |
Why?
|
| Mice | 30 | 2025 | 18198 | 0.840 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2023 | 137 | 0.800 |
Why?
|
| Long-Term Potentiation | 7 | 2017 | 103 | 0.740 |
Why?
|
| Patch-Clamp Techniques | 16 | 2015 | 271 | 0.700 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2012 | 1110 | 0.700 |
Why?
|
| Models, Neurological | 7 | 2024 | 211 | 0.690 |
Why?
|
| Mice, Inbred C57BL | 13 | 2025 | 4700 | 0.650 |
Why?
|
| Calcium | 8 | 2017 | 1009 | 0.650 |
Why?
|
| Neocortex | 2 | 2018 | 75 | 0.640 |
Why?
|
| Excitatory Postsynaptic Potentials | 12 | 2016 | 101 | 0.610 |
Why?
|
| Ion Channels | 4 | 2012 | 195 | 0.600 |
Why?
|
| In Vitro Techniques | 10 | 2014 | 808 | 0.460 |
Why?
|
| Sleep Deprivation | 2 | 2005 | 44 | 0.420 |
Why?
|
| Receptors, AMPA | 5 | 2005 | 44 | 0.420 |
Why?
|
| Axons | 2 | 2016 | 381 | 0.420 |
Why?
|
| Inhibitory Postsynaptic Potentials | 3 | 2010 | 29 | 0.410 |
Why?
|
| N-Methylaspartate | 1 | 2013 | 29 | 0.410 |
Why?
|
| Glutamic Acid | 8 | 2013 | 200 | 0.390 |
Why?
|
| Optogenetics | 2 | 2024 | 71 | 0.390 |
Why?
|
| Cues | 3 | 2022 | 80 | 0.390 |
Why?
|
| Reward | 2 | 2025 | 130 | 0.380 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 7 | 2012 | 124 | 0.370 |
Why?
|
| Sensation | 1 | 2012 | 46 | 0.370 |
Why?
|
| Dendritic Spines | 1 | 2012 | 56 | 0.370 |
Why?
|
| Sensory Deprivation | 1 | 2011 | 10 | 0.360 |
Why?
|
| Cell Compartmentation | 1 | 2011 | 38 | 0.360 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 358 | 0.350 |
Why?
|
| Potassium Channels | 5 | 2013 | 154 | 0.330 |
Why?
|
| Male | 21 | 2025 | 64613 | 0.330 |
Why?
|
| Somatosensory Cortex | 3 | 2018 | 54 | 0.320 |
Why?
|
| Tetrodotoxin | 5 | 2016 | 48 | 0.310 |
Why?
|
| Motor Activity | 1 | 2012 | 489 | 0.300 |
Why?
|
| Kinetics | 5 | 2023 | 1087 | 0.300 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 329 | 0.300 |
Why?
|
| Electric Stimulation | 6 | 2012 | 234 | 0.250 |
Why?
|
| Models, Biological | 1 | 2012 | 1375 | 0.250 |
Why?
|
| Dentate Gyrus | 1 | 2024 | 37 | 0.210 |
Why?
|
| Organ Culture Techniques | 3 | 2015 | 140 | 0.200 |
Why?
|
| Potassium Channel Blockers | 3 | 2016 | 84 | 0.190 |
Why?
|
| Gene Knock-In Techniques | 2 | 2015 | 118 | 0.190 |
Why?
|
| Sodium Channels | 2 | 2003 | 97 | 0.190 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 90 | 0.180 |
Why?
|
| NADPH Oxidase 2 | 1 | 2022 | 38 | 0.180 |
Why?
|
| Macrophages, Alveolar | 1 | 2022 | 52 | 0.180 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2022 | 69 | 0.180 |
Why?
|
| Ion Channel Gating | 3 | 2008 | 119 | 0.170 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 81 | 0.170 |
Why?
|
| Computer Simulation | 3 | 2021 | 671 | 0.170 |
Why?
|
| Electrophysiology | 3 | 2010 | 243 | 0.170 |
Why?
|
| Leukemia | 2 | 2021 | 383 | 0.150 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2014 | 542 | 0.150 |
Why?
|
| Vibrissae | 1 | 2018 | 14 | 0.140 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2013 | 83 | 0.140 |
Why?
|
| Phosphorylation | 1 | 2002 | 1571 | 0.140 |
Why?
|
| Rats, Wistar | 3 | 2015 | 298 | 0.140 |
Why?
|
| Theta Rhythm | 2 | 2010 | 22 | 0.130 |
Why?
|
| Neoplasms | 1 | 2012 | 2986 | 0.130 |
Why?
|
| Locomotion | 1 | 2017 | 59 | 0.120 |
Why?
|
| Channelrhodopsins | 1 | 2016 | 10 | 0.120 |
Why?
|
| Biophysical Phenomena | 1 | 2016 | 39 | 0.120 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 881 | 0.120 |
Why?
|
| Sodium Channel Blockers | 1 | 2016 | 24 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 607 | 0.120 |
Why?
|
| Electroporation | 2 | 2014 | 35 | 0.110 |
Why?
|
| Light | 3 | 2012 | 166 | 0.110 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 431 | 0.110 |
Why?
|
| Photic Stimulation | 3 | 2012 | 226 | 0.110 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2015 | 13 | 0.110 |
Why?
|
| Wakefulness | 1 | 2016 | 103 | 0.110 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 2006 | 2 | 0.110 |
Why?
|
| Calcium Channel Blockers | 3 | 2013 | 107 | 0.110 |
Why?
|
| Lung | 1 | 2022 | 1535 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1265 | 0.100 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2013 | 5 | 0.100 |
Why?
|
| Genes, ras | 1 | 2013 | 95 | 0.100 |
Why?
|
| Brain | 1 | 2005 | 3167 | 0.100 |
Why?
|
| Biophysics | 2 | 2012 | 47 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 2332 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 587 | 0.090 |
Why?
|
| Sodium | 1 | 2013 | 280 | 0.090 |
Why?
|
| Electric Impedance | 1 | 2012 | 71 | 0.090 |
Why?
|
| Time Perception | 1 | 2012 | 9 | 0.090 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2011 | 15 | 0.090 |
Why?
|
| Barium | 2 | 2013 | 13 | 0.090 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2011 | 15 | 0.090 |
Why?
|
| Female | 7 | 2021 | 70545 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 570 | 0.080 |
Why?
|
| Microscopy | 1 | 2011 | 118 | 0.080 |
Why?
|
| Neural Pathways | 2 | 2009 | 269 | 0.080 |
Why?
|
| Silicon | 1 | 2010 | 13 | 0.080 |
Why?
|
| Optical Fibers | 1 | 2010 | 16 | 0.080 |
Why?
|
| Synaptic Potentials | 1 | 2009 | 14 | 0.080 |
Why?
|
| Raphe Nuclei | 1 | 2009 | 16 | 0.080 |
Why?
|
| Neurons, Afferent | 1 | 2009 | 39 | 0.080 |
Why?
|
| Spider Venoms | 1 | 2009 | 6 | 0.070 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 1579 | 0.070 |
Why?
|
| Time Factors | 5 | 2014 | 6175 | 0.070 |
Why?
|
| Environment | 1 | 2009 | 149 | 0.070 |
Why?
|
| Serotonin | 1 | 2009 | 208 | 0.070 |
Why?
|
| Humans | 7 | 2026 | 130534 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2009 | 83 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2011 | 892 | 0.070 |
Why?
|
| Lighting | 1 | 2008 | 19 | 0.070 |
Why?
|
| Cell Shape | 1 | 2008 | 67 | 0.070 |
Why?
|
| Shal Potassium Channels | 1 | 2008 | 48 | 0.070 |
Why?
|
| Indoles | 2 | 2013 | 200 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2009 | 646 | 0.070 |
Why?
|
| Lasers | 1 | 2008 | 112 | 0.060 |
Why?
|
| Calcium Signaling | 2 | 2013 | 243 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 3465 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2008 | 159 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 304 | 0.060 |
Why?
|
| Algorithms | 2 | 2003 | 1669 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2009 | 1023 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2006 | 143 | 0.060 |
Why?
|
| Electrodes | 1 | 2004 | 81 | 0.050 |
Why?
|
| Glycine | 1 | 2005 | 156 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1914 | 0.050 |
Why?
|
| Homeostasis | 2 | 2022 | 713 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 105 | 0.050 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2003 | 11 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 26 | 0.050 |
Why?
|
| Kynurenic Acid | 1 | 2003 | 9 | 0.050 |
Why?
|
| Amygdala | 1 | 2003 | 73 | 0.050 |
Why?
|
| Glutamates | 1 | 2003 | 52 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2023 | 145 | 0.050 |
Why?
|
| Staurosporine | 1 | 2002 | 21 | 0.050 |
Why?
|
| Mutation | 3 | 2023 | 6064 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2003 | 135 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2884 | 0.050 |
Why?
|
| Probability | 2 | 2013 | 305 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2003 | 257 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2003 | 450 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2022 | 269 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2012 | 4664 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 236 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 560 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2022 | 336 | 0.040 |
Why?
|
| Pregnancy | 1 | 2011 | 7459 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2003 | 858 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2007 | 3812 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 384 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2021 | 821 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2002 | 618 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2014 | 2461 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 1333 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 1714 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2195 | 0.030 |
Why?
|
| Puromycin | 1 | 2014 | 11 | 0.030 |
Why?
|
| Plant Lectins | 1 | 2014 | 4 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2014 | 89 | 0.030 |
Why?
|
| Ribosomal Proteins | 1 | 2014 | 70 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 142 | 0.020 |
Why?
|
| Alkaloids | 1 | 2013 | 36 | 0.020 |
Why?
|
| Ribosomes | 1 | 2014 | 123 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2014 | 241 | 0.020 |
Why?
|
| Valine | 1 | 2013 | 110 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 421 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 240 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 412 | 0.020 |
Why?
|
| Quinolines | 1 | 2013 | 117 | 0.020 |
Why?
|
| Halorhodopsins | 1 | 2012 | 1 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 252 | 0.020 |
Why?
|
| Somatostatin | 1 | 2012 | 60 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2012 | 59 | 0.020 |
Why?
|
| Parvalbumins | 1 | 2012 | 38 | 0.020 |
Why?
|
| Touch | 1 | 2012 | 38 | 0.020 |
Why?
|
| Child | 2 | 2023 | 26263 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 765 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2014 | 380 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5049 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 370 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2012 | 105 | 0.020 |
Why?
|
| Movement | 1 | 2012 | 147 | 0.020 |
Why?
|
| Exercise Test | 1 | 2012 | 239 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2013 | 589 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6424 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2008 | 54 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 79 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 688 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1800 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 953 | 0.020 |
Why?
|
| Equipment Design | 1 | 2008 | 509 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2008 | 248 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 828 | 0.010 |
Why?
|
| United States | 1 | 2021 | 12002 | 0.010 |
Why?
|
| 4-Aminopyridine | 1 | 2003 | 28 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 356 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2003 | 246 | 0.010 |
Why?
|